Spohrer S, Dimova E, Kietzmann T, Montenarh M, Götz C. The nuclear fraction of protein kinase CK2 binds to the upstream stimulatory factors (USFs) in the absence of DNA. Cell Signal. 2016;28:23-31 pubmed publisher

Kren B, Unger G, Abedin M, Vogel R, Henzler C, Ahmed K, et al. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy. Breast Cancer Res. 2015;17:19 pubmed publisher

Trembley J, Unger G, Gomez O, Abedin J, Korman V, Vogel R, et al. Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation. Mol Cell Pharmacol. 2014;6:15-25 pubmed

Spohrer S, Groß R, Nalbach L, Schwind L, Stumpf H, Menger M, et al. Functional interplay between the transcription factors USF1 and PDX-1 and protein kinase CK2 in pancreatic ?-cells. Sci Rep. 2017;7:16367 pubmed publisher

Ahmed K, Kren B, Abedin M, Vogel R, Shaughnessy D, Nacusi L, et al. CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors. Oncotarget. 2016;7:61789-61805 pubmed publisher

Kivimäe S, Yang X, Cheyette B. All Dact (Dapper/Frodo) scaffold proteins dimerize and exhibit conserved interactions with Vangl, Dvl, and serine/threonine kinases. BMC Biochem. 2011;12:33 pubmed publisher